Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tianjin CanSino
Pharma
Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia
The FDA approved generics to Takeda's Vyvanse. Keytruda and Lenvima chalked up another trial failure. ADC opted out of a partnership with Adagene.
Angus Liu
Sep 1, 2023 8:50am
AstraZeneca signs mRNA manufacturing deal with China's CanSino
Aug 9, 2023 11:28am
Merck-Eisai, J&J-Legend, AZ-Samsung and more—Fierce Pharma Asia
Dec 17, 2021 10:20am
CanSino, Aerogen team up on inhalable COVID-19 vaccine hopeful
Dec 13, 2021 4:40pm
CanSino, AZ-SK COVID-19 vaccines and more—FiercePharmaAsia
Jul 24, 2020 10:22am
GSK, Akebia and Takeda—FiercePharmaAsia
Jul 2, 2020 10:15am
